Resistance of <it>Leishmania (Viannia) braziliensis </it>to nitric oxide: correlation with antimony therapy and TNF-α production

<p>Abstract</p> <p>Background</p> <p>Nitric oxide (NO) produced in macrophages plays a pivotal role as a leishmanicidal agent. A previous study has demonstrated that 20% of the <it>L. (V.) braziliensis </it>isolated from initial cutaneous lesions of patients...

Full description

Bibliographic Details
Main Authors: Wilson Mary E, de Moura Tatiana R, de Jesus Amelia R, Guimarães Luís H, Pereira Júlia MB, Giudice Angela, Souza Anselmo S, Carvalho Edgar M, Almeida Roque P
Format: Article
Language:English
Published: BMC 2010-07-01
Series:BMC Infectious Diseases
Online Access:http://www.biomedcentral.com/1471-2334/10/209
id doaj-d17e47f834a440ab8a74dae15012455c
record_format Article
spelling doaj-d17e47f834a440ab8a74dae15012455c2020-11-25T03:24:51ZengBMCBMC Infectious Diseases1471-23342010-07-0110120910.1186/1471-2334-10-209Resistance of <it>Leishmania (Viannia) braziliensis </it>to nitric oxide: correlation with antimony therapy and TNF-α productionWilson Mary Ede Moura Tatiana Rde Jesus Amelia RGuimarães Luís HPereira Júlia MBGiudice AngelaSouza Anselmo SCarvalho Edgar MAlmeida Roque P<p>Abstract</p> <p>Background</p> <p>Nitric oxide (NO) produced in macrophages plays a pivotal role as a leishmanicidal agent. A previous study has demonstrated that 20% of the <it>L. (V.) braziliensis </it>isolated from initial cutaneous lesions of patients from the endemic area of Corte de Pedra, Bahia, Brazil, were NO resistant. Additionally, 5 to 11% of the patients did not respond to three or more antimony treatments" (refractory patients). The aim of this study is to investigate if there is an association between the resistance of <it>L. (V.) braziliensis </it>to NO and nonresponsiveness to antimony therapy and cytokine production.</p> <p>Methods</p> <p>We evaluated the <it>in vitro </it>toxicity of NO against the promastigotes stages of <it>L. (V.) braziliensis </it>isolated from responsive and refractory patients, and the infectivity of the amastigote forms of these isolates against human macrophages. The supernatants from <it>Leishmania </it>infected macrophage were used to measure TNF-α and IL-10 levels.</p> <p>Results</p> <p>Using NaNO<sub>2 </sub>(pH 5.0) as the NO source, <it>L. (V.) braziliensis </it>isolated from refractory patients were more NO resistant (IC50 = 5.8 ± 4.8) than <it>L. (V.) braziliensis </it>isolated from responsive patients (IC50 = 2.0 ± 1.4). Four isolates were selected to infect human macrophages: NO-susceptible and NO-resistant <it>L. (V.) braziliensis </it>isolated from responsive and refractory patients. NO-resistant <it>L. (V.) braziliensis </it>isolated from refractory patients infected more macrophages stimulated with LPS and IFN-γ at 120 hours than NO-susceptible <it>L. (V.) braziliensis </it>isolated from refractory patients. Also, lower levels of TNF-α were detected in supernatants of macrophages infected with NO-resistant <it>L. (V.) braziliensis </it>as compared to macrophages infected with NO-susceptible <it>L. (V.) braziliensis </it>(p < 0.05 at 2, 24 and 120 hours), while no differences were detected in IL-10 levels.</p> <p>Conclusion</p> <p>These data suggest that NO resistance could be related to the nonresponsiveness to antimony therapy seen in American Tegumentary Leishmaniasis.</p> http://www.biomedcentral.com/1471-2334/10/209
collection DOAJ
language English
format Article
sources DOAJ
author Wilson Mary E
de Moura Tatiana R
de Jesus Amelia R
Guimarães Luís H
Pereira Júlia MB
Giudice Angela
Souza Anselmo S
Carvalho Edgar M
Almeida Roque P
spellingShingle Wilson Mary E
de Moura Tatiana R
de Jesus Amelia R
Guimarães Luís H
Pereira Júlia MB
Giudice Angela
Souza Anselmo S
Carvalho Edgar M
Almeida Roque P
Resistance of <it>Leishmania (Viannia) braziliensis </it>to nitric oxide: correlation with antimony therapy and TNF-α production
BMC Infectious Diseases
author_facet Wilson Mary E
de Moura Tatiana R
de Jesus Amelia R
Guimarães Luís H
Pereira Júlia MB
Giudice Angela
Souza Anselmo S
Carvalho Edgar M
Almeida Roque P
author_sort Wilson Mary E
title Resistance of <it>Leishmania (Viannia) braziliensis </it>to nitric oxide: correlation with antimony therapy and TNF-α production
title_short Resistance of <it>Leishmania (Viannia) braziliensis </it>to nitric oxide: correlation with antimony therapy and TNF-α production
title_full Resistance of <it>Leishmania (Viannia) braziliensis </it>to nitric oxide: correlation with antimony therapy and TNF-α production
title_fullStr Resistance of <it>Leishmania (Viannia) braziliensis </it>to nitric oxide: correlation with antimony therapy and TNF-α production
title_full_unstemmed Resistance of <it>Leishmania (Viannia) braziliensis </it>to nitric oxide: correlation with antimony therapy and TNF-α production
title_sort resistance of <it>leishmania (viannia) braziliensis </it>to nitric oxide: correlation with antimony therapy and tnf-α production
publisher BMC
series BMC Infectious Diseases
issn 1471-2334
publishDate 2010-07-01
description <p>Abstract</p> <p>Background</p> <p>Nitric oxide (NO) produced in macrophages plays a pivotal role as a leishmanicidal agent. A previous study has demonstrated that 20% of the <it>L. (V.) braziliensis </it>isolated from initial cutaneous lesions of patients from the endemic area of Corte de Pedra, Bahia, Brazil, were NO resistant. Additionally, 5 to 11% of the patients did not respond to three or more antimony treatments" (refractory patients). The aim of this study is to investigate if there is an association between the resistance of <it>L. (V.) braziliensis </it>to NO and nonresponsiveness to antimony therapy and cytokine production.</p> <p>Methods</p> <p>We evaluated the <it>in vitro </it>toxicity of NO against the promastigotes stages of <it>L. (V.) braziliensis </it>isolated from responsive and refractory patients, and the infectivity of the amastigote forms of these isolates against human macrophages. The supernatants from <it>Leishmania </it>infected macrophage were used to measure TNF-α and IL-10 levels.</p> <p>Results</p> <p>Using NaNO<sub>2 </sub>(pH 5.0) as the NO source, <it>L. (V.) braziliensis </it>isolated from refractory patients were more NO resistant (IC50 = 5.8 ± 4.8) than <it>L. (V.) braziliensis </it>isolated from responsive patients (IC50 = 2.0 ± 1.4). Four isolates were selected to infect human macrophages: NO-susceptible and NO-resistant <it>L. (V.) braziliensis </it>isolated from responsive and refractory patients. NO-resistant <it>L. (V.) braziliensis </it>isolated from refractory patients infected more macrophages stimulated with LPS and IFN-γ at 120 hours than NO-susceptible <it>L. (V.) braziliensis </it>isolated from refractory patients. Also, lower levels of TNF-α were detected in supernatants of macrophages infected with NO-resistant <it>L. (V.) braziliensis </it>as compared to macrophages infected with NO-susceptible <it>L. (V.) braziliensis </it>(p < 0.05 at 2, 24 and 120 hours), while no differences were detected in IL-10 levels.</p> <p>Conclusion</p> <p>These data suggest that NO resistance could be related to the nonresponsiveness to antimony therapy seen in American Tegumentary Leishmaniasis.</p>
url http://www.biomedcentral.com/1471-2334/10/209
work_keys_str_mv AT wilsonmarye resistanceofitleishmaniavianniabraziliensisittonitricoxidecorrelationwithantimonytherapyandtnfaproduction
AT demouratatianar resistanceofitleishmaniavianniabraziliensisittonitricoxidecorrelationwithantimonytherapyandtnfaproduction
AT dejesusameliar resistanceofitleishmaniavianniabraziliensisittonitricoxidecorrelationwithantimonytherapyandtnfaproduction
AT guimaraesluish resistanceofitleishmaniavianniabraziliensisittonitricoxidecorrelationwithantimonytherapyandtnfaproduction
AT pereirajuliamb resistanceofitleishmaniavianniabraziliensisittonitricoxidecorrelationwithantimonytherapyandtnfaproduction
AT giudiceangela resistanceofitleishmaniavianniabraziliensisittonitricoxidecorrelationwithantimonytherapyandtnfaproduction
AT souzaanselmos resistanceofitleishmaniavianniabraziliensisittonitricoxidecorrelationwithantimonytherapyandtnfaproduction
AT carvalhoedgarm resistanceofitleishmaniavianniabraziliensisittonitricoxidecorrelationwithantimonytherapyandtnfaproduction
AT almeidaroquep resistanceofitleishmaniavianniabraziliensisittonitricoxidecorrelationwithantimonytherapyandtnfaproduction
_version_ 1724599483431387136